For Immediate Release
National Football League Alumni Association and Cancer Treatment Centers of America® Extend Partnership to Enhance Prostate Cancer Awareness
Mount Laurel, NJ, Nov. 17, 2016 — The National Football League Alumni Association (NFLA) and Cancer Treatment Centers of America® (CTCA) are extending their successful partnership to educate men about the importance of prostate cancer screening.
“Almost everyone knows someone – a friend, colleague or family member – who has battled prostate cancer,” said Joe Pisarcik, former Philadelphia Eagles quarterback and president and CEO of the NFLA.
“Many members of the NFL alumni have fought this disease. Our partnership with Cancer Treatment Centers of America allows us to make millions of men aware of the risks and encourage them to get a potentially lifesaving test.”
Prostate cancer is the second most common cancer among men in the U.S.:
In September, Prostate Cancer Awareness Month, CTCA and the NFLA teamed up with legendary coaches Herm Edwards, Bill Cowher and Dick Vermeil to raise awareness of prostate cancer risks through the launch of a national “Prostate Pep Talk” campaign and distribution of a prostate cancer infographic. The trio was featured in a series of engaging public service announcements encouraging men to get screened for the disease. The PSA videos were viewed more than 1 million times, on television and via social media.
“Screening is the first defense against prostate cancer. It is a straightforward, simple test. It’s routinely performed and it saves lives,” said Sean Cavanaugh, MD, chief of radiation oncology at CTCA at Southeastern Regional Medical Center in Atlanta. “We are proud to partner with the NFLA to raise awareness about the importance of screening and remind men the best time to check for, and treat, prostate cancer is when there are no symptoms. Prostate cancer is most beatable when detected early.”
“We’re still coaches. It’s not the Xs and Os anymore. It’s about preparing players for life after football,” said Herm Edwards, ESPN NFL Analyst and former NFL player for the Philadelphia Eagles and former head coach for the New York Jets and Kansas City Chiefs.
“Prostate cancer doesn’t discriminate,” said Dick Vermeil, former head coach of the Philadelphia Eagles, St. Louis Rams and Kansas City Chiefs. “If I could go back and do it over again, I would spend a little more time talking about taking good care of yourself after football and doing the proper screenings for diseases like prostate cancer.”
Campaign details will be available in 2017. For additional prostate cancer information visit: www.ProstatePepTalk.com.
About the NFL Alumni Association
The NFL Alumni Association is a nationwide group of former National Football League players, coaches and other employees whose mission is to serve, assist and inform former players and their families. The association offers a variety of medical, financial and social programs to help members lead healthy, productive and connected lives, as well as community initiatives under its “Caring for Kids” programs. For more information please visit www.nflalumni.org.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.